TY - JOUR T1 - APPENDIX D: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy JO - CONTINUUM: Lifelong Learning in Neurology PY - 2007/08/01 AU - &NA; ED - DO - DOI: 10.1212/01.con.0000284530.12778.9b PB - Ovid Technologies (Wolters Kluwer Health) VL - 13 SP - 212 EP - 224 Y2 - 2025/04/09 ER -